NASDAQ:BLFS BioLife Solutions (BLFS) Stock Price, News & Analysis $26.63 +1.71 (+6.86%) Closing price 06/1/2026 04:00 PM EasternExtended Trading$26.63 0.00 (0.00%) As of 06/1/2026 07:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About BioLife Solutions Stock (NASDAQ:BLFS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BioLife Solutions alerts:Sign Up Key Stats Today's Range$24.51▼$27.2950-Day Range$18.59▼$26.6352-Week Range$17.86▼$29.62Volume1.26 million shsAverage Volume604,450 shsMarket Capitalization$1.30 billionP/E RatioN/ADividend YieldN/APrice Target$32.00Consensus RatingHold Company Overview BioLife Solutions (NASDAQ:BLFS) specializes in biopreservation and cold chain workflow solutions for cell and gene therapies, regenerative medicine and other advanced biologics. The company develops and markets proprietary cryopreservation media and technology platforms designed to maintain cell viability and functionality during processing, storage and transport. BioLife’s product portfolio addresses critical steps in the manufacturing and distribution of cell-based products, helping life science researchers and biopharmaceutical manufacturers protect and preserve living cells. The company’s flagship offerings include CryoStor, a family of serum-free cryopreservation media; HypoThermosol, a hypothermic storage solution for short-term cell and tissue preservation; and the ThawSTAR system, an automated cell thawing instrument that delivers controlled and reproducible warming of frozen cell therapies. In addition to its core media and instrumentation, BioLife provides technical support, training and validation services to help customers integrate its products into regulated processes and meet GMP-compliance requirements. Headquartered in Bothell, Washington, BioLife Solutions serves a global customer base spanning academic research centers, contract development and manufacturing organizations (CDMOs) and commercial biopharmaceutical companies. The company has established distribution channels in North America, Europe and Asia to support the growing demand for standardized, clinical-grade preservation solutions. BioLife’s management team is led by President and Chief Executive Officer Warren T. Thompson, whose experience in the life sciences industry has guided strategic product development and expansion initiatives. Through continuous innovation in biopreservation technologies, BioLife Solutions aims to enable the safe and reliable delivery of next-generation cell therapies worldwide.AI Generated. May Contain Errors. Read More BioLife Solutions Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks50th Percentile Overall ScoreBLFS MarketRank™: BioLife Solutions scored higher than 50% of companies evaluated by MarketBeat, and ranked 500th out of 868 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.2 / 5Analyst RatingHold Consensus RatingBioLife Solutions has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on no strong buy ratings, 3 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialBioLife Solutions has a consensus price target of $32.00, representing about 20.2% upside from its current price of $26.63.Amount of Analyst CoverageBioLife Solutions has only been the subject of 2 research reports in the past 90 days.Read more about BioLife Solutions' stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth177.78% Earnings GrowthEarnings for BioLife Solutions are expected to grow by 177.78% in the coming year, from $0.09 to $0.25 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of BioLife Solutions is -332.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of BioLife Solutions is -332.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioBioLife Solutions has a P/B Ratio of 3.45. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about BioLife Solutions' valuation and earnings. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.90% of the float of BioLife Solutions has been sold short.Short Interest Ratio / Days to CoverBioLife Solutions has a short interest ratio ("days to cover") of 10.72, which indicates bearish sentiment.Change versus previous monthShort interest in BioLife Solutions has recently increased by 4.07%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBioLife Solutions does not currently pay a dividend.Dividend GrowthBioLife Solutions does not have a long track record of dividend growth. News and Social Media2.9 / 5News Sentiment0.56 News SentimentBioLife Solutions has a news sentiment score of 0.56. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.82 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for BioLife Solutions this week, compared to 4 articles on an average week.Search Interest1 people have searched for BLFS on MarketBeat in the last 30 days. Company Ownership1.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, BioLife Solutions insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $30,134,000.00 in company stock.Percentage Held by Insiders2.20% of the stock of BioLife Solutions is held by insiders.Percentage Held by Institutions93.24% of the stock of BioLife Solutions is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about BioLife Solutions' insider trading history. Receive BLFS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioLife Solutions and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BLFS Stock News HeadlinesQ3 EPS Estimate for BioLife Solutions Decreased by AnalystJune 1 at 1:02 AM | americanbankingnews.comAnalysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO) and BioLife Solutions (BLFS)May 31 at 7:24 PM | theglobeandmail.comSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just revealed 21 banks - including JPMorgan, Goldman Sachs, and Morgan Stanley - are competing for a role in what Wall Street is calling 'Project Apex,' a potential $1.75 trillion listing Bloomberg has dubbed the biggest of all time. Dr. Mark Skousen, Macroeconomic Strategist at The Oxford Club, says a pre-IPO 'backdoor' entry still exists - and nearly 15,000 investors have already accessed his free recommendation. June is the reported target date, and the window is narrowing. | The Oxford Club (Ad)BioLife Solutions Inc (BLFS) Stock Up 3.1% and Still Undervalued -- GF Score: 73/100May 28, 2026 | gurufocus.comCasdin Partners Master Fund, L Sells 650,000 Shares of BioLife Solutions (NASDAQ:BLFS) StockMay 23, 2026 | americanbankingnews.comCasdin Partners Master Fund, L Sells 300,000 Shares of BioLife Solutions (NASDAQ:BLFS) StockMay 23, 2026 | americanbankingnews.comCasdin Partners Master Fund, L Sells 250,000 Shares of BioLife Solutions (NASDAQ:BLFS) StockMay 23, 2026 | americanbankingnews.comBioLife Solutions (NASDAQ:BLFS) Major Shareholder Sells $5,925,000.00 in StockMay 22, 2026 | insidertrades.comSee More Headlines BLFS Stock Analysis - Frequently Asked Questions How have BLFS shares performed this year? BioLife Solutions' stock was trading at $24.18 at the start of the year. Since then, BLFS stock has increased by 10.1% and is now trading at $26.63. How were BioLife Solutions' earnings last quarter? BioLife Solutions, Inc. (NASDAQ:BLFS) posted its earnings results on Thursday, May, 7th. The medical equipment provider reported $0.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.03. The medical equipment provider had revenue of $27.50 million for the quarter, compared to analysts' expectations of $25.66 million. BioLife Solutions had a positive trailing twelve-month return on equity of 1.81% and a negative net margin of 2.80%. Read the conference call transcript. Who are BioLife Solutions' major shareholders? Top institutional shareholders of BioLife Solutions include Dimensional Fund Advisors LP (2.12%), Bank of America Corp DE (1.85%), Royal Bank of Canada (1.81%) and Granahan Investment Management LLC (1.48%). Insiders that own company stock include Casdin Partners Master Fund, L, Aby J Mathew, Greef Roderick De, Michael Rice, Troy Wichterman, Todd Berard, Garrie Richardson, Karen A Foster, Sarah Aebersold, Geraint Phillips, Sean Werner, Joydeep Goswami, Marcus Schulz and Amy Duross. View institutional ownership trends. How do I buy shares of BioLife Solutions? Shares of BLFS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of BioLife Solutions own? Based on aggregate information from My MarketBeat watchlists, some other companies that BioLife Solutions investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Visa (V). Company Calendar Last Earnings5/07/2026Today6/02/2026Next Earnings (Estimated)8/06/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2w+) 1-Year History Jun 25 Sep 25 Dec 25 Mar 26 Jun 26 For the last 2 weeks, BLFS's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED PRODUCTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:BLFS CIK834365 Webwww.biolifesolutions.com Phone(425) 402-1400Fax425-402-1433Employees440Year Founded1987Price Target and Rating Average Price Target for BioLife Solutions$32.00 High Price Target$34.00 Low Price Target$30.00 Potential Upside/Downside+20.2%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($0.08) Trailing P/E RatioN/A Forward P/E Ratio295.89 P/E GrowthN/ANet Income-$4.59 million Net Margins-2.80% Pretax Margin-10.51% Return on Equity1.81% Return on Assets1.65% Debt Debt-to-Equity RatioN/A Current Ratio7.30 Quick Ratio5.50 Sales & Book Value Annual Sales$96.21 million Price / Sales13.52 Cash Flow$0.24 per share Price / Cash Flow108.83 Book Value$7.72 per share Price / Book3.45Miscellaneous Outstanding Shares48,860,000Free Float47,782,000Market Cap$1.30 billion OptionableOptionable Beta2.00 Social Links Beginner's Guide To Retirement StocksClick the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (NASDAQ:BLFS) was last updated on 6/2/2026 by MarketBeat.com Staff. From Our PartnersGold hit $4,500 - but these miners haven't caught up yet$9 trillion in U.S. debt must be refinanced in 2026 - at current rates - while the largest foreign buyers of T...Golden Portfolio | SponsoredElon Now Pays 15X More Than Your BankElon Musk's new bank is offering 6% interest per year - that's 15 times the national average of 0.4% that most...InvestorPlace | SponsoredOne coin wired into Elon's visionIt happened with Tesla. With Dogecoin. Each time, the same pattern. Every time the world buys into Elon's ...Crypto 101 Media | SponsoredHow to claim a stake in SpaceX before the June 12 IPOSpaceX is expected to go public on June 12 - and for the first time, everyday investors may have a way in befo...Brownstone Research | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | SponsoredA gold storm is coming – are you ready?The U.S. Treasury Secretary is betting big on gold - and the world's most successful investors are following s...Traders Agency | SponsoredThe cat is out the bagAlmost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLife Solutions, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLife Solutions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BLFS Stock Alerts